Hess, Jonathan L. https://orcid.org/0000-0001-8406-632X
Quinn, Thomas P.
Zhang, Chunling
Hearn, Gentry C.
Chen, Samuel
,
Beveridge, Natalie Jane
Carr, Vaughan
de Jong, Simone
Gardiner, Erin
Kelly, Brian
Kumarasinghe, Nishantha
Ophoff, Roel
Schall, Ulrich
Scott, Rodney
Stamova, Boryana
Tooney, Paul
Kong, Sek Won https://orcid.org/0000-0003-4877-7567
Cairns, Murray https://orcid.org/0000-0003-2490-2538
Tsuang, Ming T. https://orcid.org/0000-0002-0076-5340
Faraone, Stephen V.
Glatt, Stephen J. https://orcid.org/0000-0002-0360-7567
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R21MH126494, R21MH126494)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 19 October 2022
Revised: 23 February 2023
Accepted: 28 February 2023
First Online: 22 March 2023
Competing interests
: In the past year, Dr. Faraone received income, potential income, travel expenses continuing education support, and/or research support from Aardvark, Aardwolf, Akili, Atentiv, Corium, Genomind, Ironshore, Medice, Noven, Otsuka, Sandoz, Sky Therapeutics, Supernus, Tris, and Vallon. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. In previous years, he received support from Alcobra, Arbor, Aveksham, Axsome, CogCubed, Eli Lilly, Enzymotec, Impact, Janssen, KemPharm, Lundbeck/Takeda, Shire/Takeda, McNeil, NeuroLifeSciences, Neurovance, Novartis, Pfizer, Rhodes, Shire, and Sunovion. He also receives royalties from books published by Guilford Press: <i>Straight Talk about Your Child’s Mental Health</i>; Oxford University Press: <i>Schizophrenia: The Facts;</i> and Elsevier: <i>ADHD: Non-Pharmacologic Interventions</i>. In addition, he is the program director of . In the past year, Dr. Glatt has received royalties from a book published by Oxford University Press: <i>Schizophrenia: The Facts</i>, and consulting fees from Cohen Veterans Bioscience. Dr. Cairns is supported by NHMRC project grants (1147644 and 1188493) and an NHMRC Senior Research Fellowship (1121474), and a University of Newcastle College of Health Medicine and Wellbeing, Gladys M Brawn Senior Fellowship.